[Form 4] ARTIVION, INC. Insider Trading Activity

Rhea-AI Filing Summary

Artivion, Inc. (AORT) reported an insider stock transaction by its President & CEO. On 12/02/2025, the executive exercised stock options to buy 30,921 shares of common stock at an exercise price of $29.62 per share and then sold 30,921 shares of common stock in a separate transaction at a weighted average price of $45.559 per share.

The transactions were executed under a Rule 10b5-1 trading plan adopted on September 2, 2025. Following these moves, the reporting person held 800,993 shares of Artivion common stock in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mackin James P

(Last) (First) (Middle)

ARTIVION, INC.

1655 ROBERTS BLVD, NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/02/2025		M		30,921(1)	A	$29.62	831,914	D
Common Stock	12/02/2025		S		30,921(1)	D	$45.559(2)	800,993	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	$29.62	12/02/2025		M			30,921	03/05/2020	03/05/2026(3)	Common Stock	30,921	$0	0	D

Explanation of Responses:

1. The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

2. Reflects weighted average price. Range of prices were between $45.25 to $46.09. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.

Remarks:

	/s/ James P. Mackin	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Artivion (AORT) report on this Form 4?

The President & CEO of Artivion, Inc. (AORT) reported exercising stock options for 30,921 shares of common stock at $29.62 per share and selling 30,921 shares of common stock at a weighted average price of $45.559 per share on 12/02/2025.

Who is the reporting person on this Artivion (AORT) Form 4 and what is their role?

The reporting person is an officer of Artivion, Inc., serving as President & CEO. The filing is made by one reporting person who is disclosing personal transactions in Artivion common stock and stock options.

Was the Artivion (AORT) insider trade made under a Rule 10b5-1 plan?

Yes. The sale reported was effected under a Rule 10b5-1 trading plan that the reporting person adopted on September 2, 2025, as noted in the explanation of responses.

How many Artivion (AORT) shares does the insider own after the reported transactions?

After the reported option exercise and share sale, the reporting person beneficially owns 800,993 shares of Artivion common stock in direct ownership.

What stock option details are disclosed in this Artivion (AORT) Form 4?

The filing shows a stock option to buy 30,921 shares of Artivion common stock at an exercise price of $29.62 per share, granted on 03/05/2020 with an expiration date of 03/05/2026. The option vested 33 1/3% per year beginning on the first anniversary of the grant date.

What price range did the Artivion (AORT) shares sell for in the insider transaction?

The reported sale price is a weighted average of $45.559 per share. The filing notes that the individual sale prices ranged between $45.25 and $46.09, and full breakdowns are available upon request to the reporting person.